After serving 4 years as co-Editor of the journal Fabio Cominelli, MD, PhD, has been named Editor-in-Chief and Sonia Friedman, MD, FACG, who is joining the editorial leadership, has been named Deputy Editor.
Washington, D.C. - Today 29 patient and consumer groups representing millions of people nationwide with pre-existing health conditions issued the following statement in response to administration’s final rule.
NEW YORK, NY – Today, 48 national health organizations sent a letter to members of Congress urging them to fund critical education about COVID-19 and cancelled research activities as a result of the pandemic.
The Crohn’s & Colitis Foundation (the Foundation) is pleased to announce five new members of its National Board of Trustees, which oversees the management of the organization’s policies, practices, principles, affairs, funds, and property.
NEW YORK, NY – The cost of care for inflammatory bowel disease (IBD) in the United States has increased significantly over the past five years, according to the results of the Crohn’s & Colitis Foundation’s cost of care study.
NEW YORK, NY – Today, the Crohn’s & Colitis Foundation released its new five-year research agenda to address unmet needs in the inflammatory bowel disease (IBD) research community and provide a roadmap for not only the Foundation but also the IBD research community at-large.
New York, New York – The American College of Gastroenterology (ACG), the American Gastroenterological Association (AGA), and the Crohn’s & Colitis Foundation (Foundation), in partnership with Pfizer, Inc., have announced the results of a request for proposal (RFP) to address vaccine utilizati
New York, New York – The Crohn’s & Colitis Foundation is launching a new open access journal to engage, inform, and catalyze dialogue on state-of-the-art, comprehensive care for more than 3 million Americans living with inflammatory bowel diseases (IBD).
CAMBRIDGE, England—PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today announced details of a jointly sponsored study with the US Crohn’s & Colitis Foundation.